Evidence map›Paper›PMID 34712447›Full record

ArticleMiddle East journal of digestive diseases2021

Evaluating Pancreatic index in Patients with and without Metabolic Syndrome.

Zahra Mohammadmirzaei, Habib Farahmand, Jafar Ahmadi, Sajad Rezvan, Enayatollah Noori, Ahmad Hormati

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Middle East journal of digestive diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zahra MohammadmirzaeiFaculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Habib FarahmandDepartment of Radiology, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Jafar AhmadiDepartment of Radiology, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Sajad RezvanResident of Radiology, Department of Radiology, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Enayatollah NooriMedical Doctor of Qom University of Medical Sciences, Qom, Iran.
Ahmad HormatiGastroenterology and Hepatology Disease Research Center Qom University of Medical Science, Iran.
Rafsanjan University of Medical Sciences · IRQom University of Medical Science and Health Services · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Metabolic syndrome can be considered as a combination of metabolic disorders that may led to an increased risk of some diseases such type II diabetes, cardiovascular diseases, myocardial infarction, and is the cause of mortality from coronary artery disease. Its prevalence is particularly high in women. There is evidence that pancreatic fat, as a key factor in non-alcoholic fatty liver and metabolic syndrome, numerates as an early indicator of abnormal fat deposition. METHODS In this study, we enrolled 262 patients, who were admitted to Ali Ibn Abi Talib Hospital in Rafsanjan city, using the non-random-sequential method. Data collection tools were a questionnaire containing demographic characteristics (age, sex, history of diseases, etc.) and a checklist including MetS (based on NCEP/ATP III criteria and Diabetes Committee), pancreatic density (P), and spleen (S) and pancreatic index (P/S). One-way ANOVA and Post-Hoc and Chi-square tests were used for statically analyses. RESULTS The prevalence of metabolic syndrome was 34.8%, index of pancreas in the group without and with metabolic syndrome were 0.85 ± 0.11 and 0.74 ± 0.29 Hounsfield Units, respectively. CONCLUSION Compared with the group with at least one criterion and the group with the complete criteria (

Indexed as

Cardiovascular diseaseMetabolic syndromeType II diabetes

Identifiers

PMID34712447
PMCPMC8531923
OpenAlexW3159971197

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.